Home Markets Tempus stock rises after FDA approval for tumor-only test

Tempus stock rises after FDA approval for tumor-only test

May 29, 2026 comments off

Original source: https://www.investing.com/news/stock-market-news/tempus-stock-rises-after-fda-approval-for-tumoronly-test-93CH-4716624

You May Also Like

Elice shares plunge 28% on debut as investor doubts over AI trade deepen

Rubio kicks off India visit with trade deal, Russian oil on agenda

Software upgrades eat nearly a third of companies’ IT budgets, survey finds

Waymo plans to quintuple fleet to 20,000, Semafor reports

Honeywell Aerospace sees business aviation growth on rising aircraft use

BHP Q1 copper output falls 19% on lower grades, disruptions